FGF18 Enhances Migration and the Epithelial-Mesenchymal Transition in Breast Cancer by Regulating Akt/GSK3β/Β-Catenin Signaling

Background/Aims: Fibroblast growth factors (FGFs) and their high-affinity receptors contribute to autocrine and paracrine growth stimulation in several human malignant tumors, including breast cancer. However, the mechanisms underlying the carcinogenic actions of FGF18 remain unclear. Methods: The transcription level of FGF18 under the hypoxic condition was detected with quantitative PCR (qPCR). A wound-healing assay was performed to assess the role of FGF18 in cell migration. A clonogenicity assay was used to determine whether FGF18 silencing affected cell clonogenicity. Western blotting was performed to investigate Akt/GSK3β/β-catenin pathway protein expression. Binding of β-catenin to the target gene promoter was determined by chromatin immunoprecipitation (ChIP) assays. Results: FGF18 promoted the epithelial-mesenchymal transition (EMT) and migration in breast cancer cells through activation of the Akt/GSK3β/β-catenin pathway. FGF18 increased Akt-Ser473 and -Thr308 phosphorylation, as well as that of GSK3β-Ser9. FGF18 also enhanced the transcription of proliferation-related genes (CDK2, CCND2, Ki67), metastasis-related genes (TGF-β, MMP-2, MMP-9), and EMT markers (Snail-1, Snail-2, N-cadherin, vimentin, TIMP1). β-catenin bound to the target gene promoter on the ChIP assay. Conclusion: FGF18 contributes to the migration and EMT of breast cancer cells following activation of the Akt/GSK3β/β-catenin pathway. FGF18 expression may be a potential prognostic therapeutic marker for breast cancer.

[1]  Zhidong Lv,et al.  MiR-212-5p Suppresses the Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer by Targeting Prrx2 , 2017, Cellular Physiology and Biochemistry.

[2]  Jinshan Zhang,et al.  Elevated Expression of Zinc Finger Protein 703 Promotes Cell Proliferation and Metastasis through PI3K/AKT/GSK-3β Signalling in Oral Squamous Cell Carcinoma , 2017, Cellular Physiology and Biochemistry.

[3]  Hui-Li Qu,et al.  Silencing of Prrx2 Inhibits the Invasion and Metastasis of Breast Cancer both In Vitro and In Vivo by Reversing Epithelial-Mesenchymal Transition , 2017, Cellular Physiology and Biochemistry.

[4]  F. Meng,et al.  LAPTM4B Predicts Axillary Lymph Node Metastasis in Breast Cancer and Promotes Breast Cancer Cell Aggressiveness in Vitro , 2017, Cellular Physiology and Biochemistry.

[5]  G. Hortobagyi,et al.  Current challenges of metastatic breast cancer , 2016, Cancer and Metastasis Reviews.

[6]  Ping Yang,et al.  Gankyrin sustains PI3K/GSK-3β/β-catenin signal activation and promotes colorectal cancer aggressiveness and progression , 2016, Oncotarget.

[7]  L. V. van't Veer,et al.  70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer. , 2016, The New England journal of medicine.

[8]  Jordan Anaya,et al.  OncoLnc: linking TCGA survival data to mRNAs, miRNAs, and lncRNAs , 2016, PeerJ Comput. Sci..

[9]  H. Ouyang,et al.  Transcriptional Regulation of JARID1B/KDM5B Histone Demethylase by Ikaros, Histone Deacetylase 1 (HDAC1), and Casein Kinase 2 (CK2) in B-cell Acute Lymphoblastic Leukemia* , 2015, The Journal of Biological Chemistry.

[10]  C. Criscitiello,et al.  Targeting fibroblast growth factor receptor pathway in breast cancer , 2015, Current opinion in oncology.

[11]  M. Lai,et al.  GDF15 promotes EMT and metastasis in colorectal cancer , 2015, Oncotarget.

[12]  B. Tang,et al.  An hTERT/ZEB1 complex directly regulates E-cadherin to promote epithelial-to-mesenchymal transition (EMT) in colorectal cancer , 2015, Oncotarget.

[13]  L. Pusztai,et al.  A genome-wide approach to link genotype to clinical outcome by utilizing next generation sequencing and gene chip data of 6,697 breast cancer patients , 2015, Genome Medicine.

[14]  Sydney L. Stoops,et al.  Small molecule/ML327 mediated transcriptional de-repression of E-cadherin and inhibition of epithelial-to-mesenchymal transition , 2015, Oncotarget.

[15]  H. Ouyang,et al.  Protein Phosphatase 1 (PP1) and Casein Kinase II (CK2) regulate Ikaros‐mediated repression of TdT in thymocytes and T‐cell leukemia , 2014, Pediatric blood & cancer.

[16]  I. Hedenfalk,et al.  Molecular Subtyping of Serous Ovarian Tumors Reveals Multiple Connections to Intrinsic Breast Cancer Subtypes , 2014, PloS one.

[17]  E. Oliva,et al.  FGF18 as a prognostic and therapeutic biomarker in ovarian cancer. , 2013, The Journal of clinical investigation.

[18]  M. Sormani,et al.  Identification and Validation of a New Set of Five Genes for Prediction of Risk in Early Breast Cancer , 2013, International journal of molecular sciences.

[19]  C. Delacourt,et al.  Profiling target genes of FGF18 in the postnatal mouse lung: possible relevance for alveolar development. , 2011, Physiological genomics.

[20]  T. Mohr,et al.  Up‐regulation of the fibroblast growth factor 8 subfamily in human hepatocellular carcinoma for cell survival and neoangiogenesis , 2011, Hepatology.

[21]  M. J. van de Vijver,et al.  The 70-gene prognosis signature predicts early metastasis in breast cancer patients between 55 and 70 years of age. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[22]  S. Spiegl-Kreinecker,et al.  Fibroblast growth factor receptor 3-IIIc mediates colorectal cancer growth and migration , 2010, British Journal of Cancer.

[23]  S. Paik,et al.  Prediction of adjuvant chemotherapy benefit in endocrine responsive, early breast cancer using multigene assays. , 2009, Breast.

[24]  Ahmed H. Tewfik,et al.  Early detection of ovarian cancer using group biomarkers , 2008, Molecular Cancer Therapeutics.

[25]  W. Berger,et al.  FGF18 in colorectal tumour cells: autocrine and paracrine effects. , 2007, Carcinogenesis.

[26]  D. Ornitz,et al.  FGF18 is required for early chondrocyte proliferation, hypertrophy and vascular invasion of the growth plate. , 2007, Developmental biology.

[27]  A. Gressner,et al.  Fibroblast growth factor 16 and 18 are expressed in human cardiovascular tissues and induce on endothelial cells migration but not proliferation. , 2006, Biochemical and biophysical research communications.

[28]  A. Guntur,et al.  Glycogen synthase kinase 3 controls endochondral bone development: contribution of fibroblast growth factor 18. , 2005, Developmental biology.

[29]  M. Buschmann,et al.  Fibroblast Growth Factor (FGF) 18 Signals through FGF Receptor 3 to Promote Chondrogenesis* , 2005, Journal of Biological Chemistry.

[30]  Yusuke Nakamura,et al.  Disruption of Fibroblast Growth Factor Signal Pathway Inhibits the Growth of Synovial Sarcomas: Potential Application of Signal Inhibitors to Molecular Target Therapy , 2005, Clinical Cancer Research.

[31]  M. Cronin,et al.  Gene expression markers for breast cancer prognosis of , 2004 .

[32]  Yusuke Nakamura,et al.  Involvement of the FGF18 gene in colorectal carcinogenesis, as a novel downstream target of the beta-catenin/T-cell factor complex. , 2003, Cancer research.

[33]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[34]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[35]  R. Bicknell,et al.  Hypoxia and oxidative stress in breast cancer: Oxidative stress: its effects on the growth, metastatic potential and response to therapy of breast cancer , 2001, Breast Cancer Research.

[36]  F. McCormick,et al.  Differential Regulation of Glycogen Synthase Kinase 3β by Insulin and Wnt Signaling* , 2000, The Journal of Biological Chemistry.

[37]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[38]  Randall T Moon,et al.  Mechanism and function of signal transduction by the Wnt/β-catenin and Wnt/Ca2+ pathways , 1999, Oncogene.

[39]  Michael Kühl,et al.  Functional interaction of β-catenin with the transcription factor LEF-1 , 1996, Nature.

[40]  S. Hellman.  Dogma and inquisition in medicine. Breast cancer as a case study , 1993, Cancer.

[41]  S. Noguchi,et al.  Multi-gene classifiers for prediction of recurrence in breast cancer patients , 2015, Breast Cancer.

[42]  T. Haque,et al.  A review of FGF18: Its expression, signaling pathways and possible functions during embryogenesis and post-natal development. , 2007, Histology and histopathology.

[43]  Josef Gotzmann,et al.  Molecular aspects of epithelial cell plasticity: implications for local tumor invasion and metastasis. , 2004, Mutation research.

[44]  T. Barrette,et al.  ONCOMINE: a cancer microarray database and integrated data-mining platform. , 2004, Neoplasia.